A recent study on DNA microarray technology highlights its essential role in enabling high-throughput analysis of large numbers of genes through arrays of probes integrated on a solid-phase support.

Study of 99 pediatric patients found clinically significant CNVs in 30% of cases, supporting CMA as a first-tier test for developmental delay and ID. Clinically significant CNVs were identified in 30% ...

ROCHESTER, N.Y. — The future of DNA and disease prevention is front and center in Rochester. Rochester Regional Health says it is now the first health care system in the region to offer free genetic ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...

When it came time to start a family, Sarah Elizabeth Orlando, 33, knew she would go about it differently. Before she was born, an in-utero amniocentesis had confirmed she carried the gene for fragile ...

MINNEAPOLIS — By definition, a variant of unknown significance identified in an individual with cardiomyopathy can leave physicians wondering what to do with the information. Don’t discard so-called ...

ROCHESTER, N.Y. – October is Breast Cancer Awareness Month, and genetic testing proved to be lifesaving for the women featured in this story. Jodi Lavery discovered she had a BRCA-2 gene mutation, ...

In honor of Breast Cancer Awareness Month, the TODAY show, with the help of breast cancer survivors Jill Martin and Sheryl Crow, hosted Pink Power, an event dedicated to encouraging viewers and fans ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Genetic testing is rapidly moving genomics from a niche specialty to becoming more integrated into mainstream clinical practice. Once deployed primarily to diagnose rare and inherited conditions after ...